Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 4, 2013, Pages 483-490

  Oyarzun Ampuero, Felipe A ^a,b   Rivera Rodriguez, Gustavo R ^a,c   Alonso, Maria J ^a,c   Torres, Dolores ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF CHILE   (Chile)

^c Universidade de Santiago de Compostela and Instituto de Investigación Sanitaria de Santiago de Compostela   (Spain)

Author keywords

Cancer; Hyaluronic acid; Hydrophobic drugs; Intracellular delivery; Nanocapsules; Nanocarriers

Indexed keywords

CATIONIC SURFACTANT; DOCETAXEL; DRUG VEHICLE; HYALURONIC ACID; NANOCAPSULE; NANOCARRIER;

ADSORPTION; ARTICLE; CANCER CELL; CELL CULTURE; CELL VIABILITY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; HUMAN; HUMAN CELL; IC 50; IONIC STRENGTH; LUNG CANCER; MOLECULAR WEIGHT; NANOEMULSION; NANOENCAPSULATION; PHYSICAL CHEMISTRY; POWDER; PRIORITY JOURNAL; SURFACE CHARGE; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; ZETA POTENTIAL;

EID: 84879467407     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.05.008     Document Type: Article

References (50)

1. Abdelwhaed, W., Degobert, G., Fessi, H., 2006. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur. J. Pharm. Biopharm. 63, 87-95.
2. Ahmed, I.S., Ayres, J.W., 2011. Comparison of in vitro and in vivo performance of a colonic delivery system. Int. J. Pharm. 409, 169-177.
3. Akima, K., Ito, H., Iwata, Y., Matsuo, K., Watari, N., Yanagi, M., Hagi, H., Oshima, K., Yagita, A., Atomi, Y., Tatekawa, I., 1996. Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity. J. Drug Target. 4, 1-8. (Pubitemid 26257699)
4. Auzenne, E., Ghosh, S.C., Khodadadian, M., Rivera, B., Farquhar, D., Price, R.E., Ravoori, M., Kundra, V., Freedman, R.S., Klostergaard, J., 2007. Hyaluronic acidpaclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia 9, 479-486. (Pubitemid 46983450)
5. Bae, K.H., Lee, Y., Park, T.G., 2007. Oil-encapsulating PEO-PPO-PEO/PEG shell crosslinked nanocapsules for target-specific delivery of paclitaxel. Biomacromolecules 8, 650-656. (Pubitemid 46323286)
6. Bassi, P.F., Volpe, A., D'Agostino, D., Palermo, G., Renier, D., Franchini, S., Rosato, A., Racioppi, M., 2011. Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. J Urol. 185, 445-449.
7. Calvo, C., Remuñan-López, Vila-Jato, J.L., Alonso, M.J., 1997. Development of positively charged colloidal drug carries: chitosan-coated polyester nanocapsules and submicron-emulsions. Colloid. Polym. Sci. 275, 46-53.
8. Choi, M.J., Briancon, S., Andrieu, J., Min, S.G., Fessi, H., 2004. Effect of freeze-drying process conditions on the stability of nanoparticles. Dry Technol. 22, 335-346. (Pubitemid 38502687)
9. Choi, K.Y., Min, K.H., Na, J.H., Choi, K., Kim, K., Park, J.H., Kwon, I.C., Jeong, S.Y., 2009. Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution. J. Mater. Chem. 19, 4102-4107.
10. Choi, K.Y., Saravanakumar, G., Park, J.H., Park, K., 2012. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf. B Biointerfaces 99, 82-94.
11. Coradini, D., Pellizzaro, C., Abolafio, G., Bosco, M., Scarlata, I., Cantoni, S., Stucchi, L., Zorzet, S., Turrin, C., Sava, G., Perbellini, A., Daidone, M.G., 2004. Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: a preclinical study. Invest. New Drugs 22, 207-217. (Pubitemid 39012560)
12. Crown, J., O'Leary, M., 2000. The taxanes: an update. Lancet 355, 1176-1178. (Pubitemid 30172946)
13. El-Dakdouki, M.H., Zhu, D.C., El-Boubbou, K., Kamat, M., Chen, J., Li, W., Huangm, X., 2012. Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells. Biomacromolecules 13, 1144-1151.
14. Eliaz, R.E., Szoka Jr., F.C., 2001. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res. 61, 2592-2601. (Pubitemid 32685844)
15. Eliaz, R.E., Nir, S., Marty, C., Szoka Jr., F.C., 2004. Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Res. 64, 711-718. (Pubitemid 38120914)
16. Freitas, C., Müller, R.H., 1998. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN) dispersions. Int. J. Pharm. 168, 221-229. (Pubitemid 28349963)
17. Galer, C.E., Sano, D., Ghosh, S.C., Hah, J.H., Auzenne, E., Hamir, A.N., Myers, J.N., Klostergaard, J., 2011. Hyaluronic acid-paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acidmediated mechanism. Oral Oncol. 47, 1039-1047.
18. Garcion, E., Lamprecht, A., Heurtault, B., Paillard, A., Aubert-Pouessel, A., Denizot, B., Menei, P., Benoit, J.P., 2006. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol. Cancer Ther. 5, 1710-1722. (Pubitemid 44323239)
19. Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., 2002a. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19, 875-880. (Pubitemid 34692585)
20. Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., 2002b. Properties of polyethylene glycol 660 12-hydroxy stearate at a triglyceride/water interface. Int. J. Pharm. 242, 167-170.
21. Hyung, W., Ko, H., Park, J., Lim, E., Park, S.B., Park, Y.J., Yoon, H.G., Suh, J.S., Haam, S., Huh, Y.M., 2008. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment. Biotechnol. Bioeng. 99, 442-454. (Pubitemid 351158291)
22. Journo-Gershfeld, G., Kapp, D., Shamay, Y., Kopecěk, J., David, A., 2012. Hyaluronan oligomers-HPMA copolymer conjugates for targeting paclitaxel to CD44-overexpressing ovarian carcinoma. Pharm. Res. 29, 1121-1133.
23. Khalid, M.N., Simard, P., Hoarau, D., Dragomir, A., Leroux, J.C., 2006. Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm. Res. 623, 752-758.
24. Lacoeuille, F., Hindre, F., Moal, F., Roux, J., Passirani, C., Couturier, O., Cales, P., Le Jeune, J.J., Lamprecht, A., Benoit, J.P., 2007. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int. J. Pharm. 344, 143-149. (Pubitemid 47464828)
25. Lee, S.H., Yoo, S.D., Lee, K.H., 1999. J. Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography. Chromatogr. B: Biomed. Sci. Appl. 724, 357-363. (Pubitemid 29148097)
26. Lee, H., Lee, K., Park, T.G., 2008. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjugate Chem. 19, 1319-1325. (Pubitemid 351874956)
27. Lee, S.J., Ghosh, S.C., Han, H.D., Stone, R.L., Bottsford-Miller, J., Shen, D.Y., Auzenne, E.J., Lopez-Araujo, A., Lu, C., Nishimura, M., Pecot, C.V., Zand, B., Thanapprapasr, D., Jennings, N.B., Kang, Y., Huang, J., Hu, W., Klostergaard, J., Sood, A.K., 2012. Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma. Clin. Cancer Res. 18, 4114-4121.
28. Lozano, M.V., Torrecilla, D., Torres, D., Vidal, A., Dominguez, F., Alonso, M.J., 2008. Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers. Biomacromolecules 9, 2186-2193.
29. Lozano, M.V., Esteban, H., Brea, J., Loza, M.I., Torres, D., Alonso, M.J., 2012. Intracellular delivery of docetaxel using freeze-dried polysaccharide nanocapsules. J. Microencapsul. 30, 181-188.
30. Lozano, M.V., Lollo, G., Alonso-Nocelo, M., Brea, J., Vidal, A., Torres, D., Alonso, M.J., 2013. Polyarginine nanocapsules: a new platform for intracellular drug delivery. J. Nanopart. Res. 15, 1515-1528.
31. Luo, Y., Prestwich, G.D., 1999. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjugate Chem. 10, 755-763. (Pubitemid 29456361)
32. Mizrahy, S., Raz, S.R., Hasgaard, M., Liu, H., Soffer-Tsur, N., Cohen, K., Dvash, R., Landsman-Milo, D., Bremer, M.G., Moghimi, S.M., Peer, D., 2011. Hyaluronancoated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. J. Control. Release 156, 231-238.
33. Mossman, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
34. Ossipov, D.A., 2010. Nanostructured hyaluronic acid-based materials for active delivery to cancer. Expert Opin. Drug Deliv. 7, 681-703.
35. Peer, D., Margalit, R., 2004a. Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia 6, 343-353. (Pubitemid 38924849)
36. Peer, D., Margalit, R., 2004b. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int. J. Cancer 108, 780-789. (Pubitemid 38076412)
37. Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., 2007. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760. (Pubitemid 350223348)
38. Prego, C., García, M., Torres, D., Alonso, M.J., 2005. Transmucosal macromolecular drug delivery. J. Control Release 101, 151-162. (Pubitemid 39600979)
39. Prego, C., Torres, D., Alonso, M.J., 2006. Chitosan nanocapsules: a new carrier for nasal peptide delivery. J. Drug Del. Sci. Technol. 16, 331-337. (Pubitemid 44519255)
40. Rivkin, I., Cohen, K., Koffler, J., Melikhov, D., Peer, D., Margalit, R., 2010. Paclitaxelclusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials 31, 7106-7114.
41. Rosato, A., Banzato, A., De Luca, G., Renier, D., Bettella, F., Pagano, C., Esposito, G., Zanovello, P., Bassi, P., 2006. HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer. Urol. Oncol. 3, 207-215.
42. Rowe, R.C., Sheskey, P.J., Cook, W.G., Fenton, M.E., 2012. Handbook of Pharmaceutical Excipients, seventh ed. Royal Pharmaceutical Society, London.
43. Santander-Ortega, M.J., Peula-García, J.M., Goycoolea, F.M., Ortega-Vinuesa, J.L., 2011. Chitosan nanocapsules: effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability. Colloids Surf. B. Biointerfaces 82, 571-580.
44. Saravanakumar, G., Choi, K.Y., Yoon, H.Y., Kim, K., Park, J.H., Kwon, I.C., Park, K., 2010. Hydrotropic hyaluronic acid conjugates: synthesis, characterization, and implications as a carrier of paclitaxel. Int. J. Pharm. 394, 154-161.
45. Surace, C., Arpicco, S., Dufaÿ-Wojcicki, A., Marsaud, V., Bouclier, C., Clay, D., Cattel, L., Renoir, J.M., Fattal, E., 2009. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Mol. Pharm. 6, 1062-1073.
46. Ten Tije, A.J., Verweij, J., Loos, W.J., Sparreboom, A., 2003. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin. Pharmacokinet. 42, 665-685. (Pubitemid 36936530)
47. Toole, B.P., 2004. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528-539. (Pubitemid 38868622)
48. Torrecilla, D., Lozano, M.V., Lallana, E., Neissa, J.I., Novoa-Carballal, R., Vidal, A., Fernández-Megia, E., Torres, F., et al., 2013. Anti-Tumor Efficacy of Chitosan-g Poly(ethyleneglycol) Nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs non-functionalized nanocapsules. Eur. J. Pharm. Biopharm. 83, 330-337.
49. Wu, J.L., Liu, C.G., Wang, X.L., Huang, Z.H., 2012. Preparation and characterization of nanoparticles based on histidine-hyaluronic acid conjugates as doxorubicin carriers. J. Mater. Sci. Mater. Med. 23, 1921-1929.
50. Yang, X.Y., Li, Y.X., Li, M., Zhang, L., Feng, L.X., Zhang, N., in press. Hyaluronic acidcoated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett. http://dx.doi.org/10.1016/j.canlet.2012.07.002.